Zoeken naar een onderzoek

International Second Immunoglobulin Dose in Guillain-Barré Syndrome patients with poor prognosis.
NO LONGER A SEPARATE STUDY. THIS STUDY WILL BELONG TO THE IGOS STUDY (NTR 3290).

To determine whether a second dose of IVIg in GBS patients with a poor prognosis improves functional outcome after 4 weeks. Secondary outcomes include functional outcome after 8, 12 and 26 weeks, duration of mechanical ventilation, length of…

PORTEC-4: Randomised trial investigating the role and optimal dose of vaginal brachytherapy for endometrial cancer.

Although vaginal brachytherapy reduces vaginal recurrence compared to observation after surgery for endometrial cancers with high-intermediate risk features, ultimate 5-year vaginal control including treatment for relapse will be similar, and a…